Merck & Co: Spannende Portfolio-Ergänzung - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Merck & Co-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…
130,103$
-0,10%
Echtzeit-Aktienkurs Merck & Co. Inc.
Bid:
Ask:
Nachrichten zur Merck & Co. Inc. Aktie
Mercks Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls
…
Merck to Buy Harpoon Therapeutics for $680 Million
…
Merck to buy Harpoon Therapeutics for $680 million By Reuters
Merck to buy Harpoon Therapeutics for $680 million…
Harpoon Therapeutics doubles on report Merck nears takeover By Investing.com
Harpoon Therapeutics doubles on report Merck nears takeover…
Merck & Co: Top Pick für 2024 - Aktienanalyse
New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Mizuho Securities USA:
Mizuho Securities USA rät in einer aktuellen Aktienanalyse weiterhin zum…
Merck close to acquiring cancer specialist Harpoon Therapeutics
Merck & Co Inc (NYSE:MRK) is close to acquiring Harpoon Therapeutics Inc, a cancer drug developer, for about $700 million to…
Desaster bei Boeing, Merck will Harpoon Therapeutics und Reserve Split bei Qiagen - BÖRSE TO GO
Die Reihe der Desaster bei Boeing will nicht abreißen. Der Abriss einer Tür mitten im Flug einer Boeing Max Maschine…
Merck in talks to acquire Harpoon Therapeutics for around $700M - Bloomberg
…
Merck reportedly in talks to buy drugmaker for more than double Friday’s price
…
Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates
Merck (MRK) begins global pivotal studies on bomedemstat, nemtabrutinib, MK-2870 and MK-5684.…
Merck looks to tap into obesity drug market
…
Top Analyst Reports for Merck, Salesforce & Philip Morris
Todays Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM)…
Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)
…
AKTIE IM FOKUS: Merck & Co unbeirrt auf Rallykurs - Obesity-Markt lockt
NEW YORK (dpa-AFX) - Die Aktien des US-Pharmaherstellers Merck & Co sind am Donnerstag auf…
Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen By Investing.com
Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen…
Merck stock poised for sixth straight gain
…
Merck & Co: Schätzungen und Kursziel erhöht - Aktienanalyse
New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Citigroup:
Die Analysten der Citigroup erhöhen in einer aktuellen Aktienanalyse ihr Kursziel…
JEFFERIES stuft MERCK KGAA auf Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA auf "Buy" mit einem Kursziel von…
C4 Therapeutics (CCCC) Gains 310% in 3 Months: Heres Why
C4 Therapeutics (CCCC) shares surge on a licensing deal to develop degrader-antibody conjugates with Merck and positive data from CFT7455…
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
The pairs collaboration is making waves, and theres more to come.…
Treffer +33%! Merck Aktie hat Erholungskurs eingeschlagen!
Kaufsignal und Widerstand sind geschafft. Diejenigen unserer Abonnenten, die uns Ihr Vertrauen geschenkt hatten und zu unserem genannten Einstiegskurs mit…
LEG Immobilien, PNE, Bayer, Merck, Tomra, Block: Was sind Knockout-Hebel-Zertifikate und wie ...
Bei Knockout-Hebel-Zertifikaten wird auf einen bestimmten Wert gesetzt, für den es einen bestimmten Hebel und einen definierten Knockout-Kurs gibt, der…
Merck (MRK) & Daiichi Sankyos Lung Cancer ADC Gets Priority Tag
Merck (MRK) and Daiichi Sankyos regulatory filing for HER3-DXd gets the FDAs priority review grant for the treatment of adult…
Merck: Smart Value For Potentially Strong Total Returns
…
Merck: An Excellent Dividend Grower With Strong Annual Total Return Potential
…
Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth
…
Is Merck & Co., Inc.s (NYSE:MRK) Recent Stock Performance Tethered To Its Strong Fundamentals?
Merck (NYSE:MRK) has had a great run on the share market with its stock up by a significant 5.7% over…
Pharma Stock Roundup: FDA Nod to AZNs Eplontersen, CRL to MRKs Cough Candidate
FDA approves AstraZeneca (AZN) and Ionis (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Mercks chronic cough candidate, gefapixant.…
Merck: Im nächsten Jahr dann wieder vorne mit dabei?
Während der DAX 2023 ein überdurchschnittlich starkes Börsenjahr ausweisen wird, gehört eine Aktie, die den Index in den letzten zehn…
Mercks (MRK) Chronic Cough Drug Gets Another CRL From FDA
Per the FDA, the data submitted by Merck (MRK) for its chronic cough drug did not provide sufficient evidence to…
FDA Accepts Mercks (MRK) BLA for 21-Valent Pneumococcal Jab
The FDA grants priority review to Mercks (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A…
Better Dividend Stock: Bristol Myers Squibb or Merck? @themotleyfool #stocks $BMY $MRK $^GSPC
These two pharma stocks have sizable dividend yields. Which is the better buy right now?…
Better Dividend Stock: Bristol Myers Squibb or Merck?
These two pharma stocks have sizable dividend yields. Which is the better buy right now?…
Merck: Hochstufung
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von HSBC stufen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK) von…
Merck: Merckliche Rückschläge - Rating gesenkt - Aktienanalyse
Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
The FDA approves Pfizers (PFE) Padcev in combination with Mercks (MRK) Keytruda for adult patients with advanced bladder cancer. Stock…
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
Following these approvals, Mercks (MRK) Keytruda is approved for seven gastrointestinal cancers in the European Union. Overall, the drug is…
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has…
Merck gets FDA approval for kidney cancer drug Welireg
…
Merck bekommt Zulassungsempfehlung der EMA für pädiatrische Bilharziose-Arznei
FRANKFURT (Dow Jones)--Das deutsche Pharmaunternehmen Merck KGaA hat für sein Medikament Arpraziquantel für die Behandlung der Wurmkrankheit Bilharziose bei Kindern…
Merck KGaA-Aktie mit Kursgewinnen (141,60 €)
Die Merck-Aktie notiert heute etwas fester. Der jüngste Kurs betrug 141,60 Euro. Jahreschart der Merck KGaA-Aktie, Stand 15.12.2023 Ein Preisanstieg…
Prepacked Chromatography Columns Global Industry Analysis and Forecast 2023-2028, Featuring Agilent Technologies, Bio-RAD Laboratories, Merck, Repligen and Shimadzu
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Prepacked Chromatography Columns Market: Global Industry Trends, Share, Size, Growth,…
FDA Expands Mercks (MRK) Welireg Label in Renal Cell Carcinoma
Per Merck (MRK), the latest FDA approval to Welireg marks the first time a new treatment has been approved in…
Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added…
Merck KGaA-Aktie: Kurs klettert leicht (139,25 €)
Im deutschen Wertpapierhandel liegt der Anteilsschein von Merck derzeit im Plus. Das Papier kostete zuletzt 139,25 Euro. Ein Wertzuwachs in…
Modernas stock jumps on trial of treatment with Merck cancer drug
Modernas stock jumps on trial of treatment with Merck cancer drug…
: Moderna’s stock rallies 7.9% after announcing positive data in trial of melanoma treatment combined with Merck’s Keytruda
Moderna Inc.’s stock MRNA soared 7% early Thursday, after the biotech and partner Merck MRK announced positive data from a…
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the…
Moderna Stock Surges After Positive Trial Results
Moderna shares rose more than 12% in premarket trading after the company and partner Merck [disclosed positive trial results](https://www.merck.com/news/moderna-and-merck-announce-mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-met-primar…